Surgery Partners, Inc. SGRY
$13.11
-$0.25-1.84%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 4.69% | -8.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.69% | -8.37% | |||
| Cost of Revenue | 1.23% | -3.28% | |||
| Gross Profit | 18.73% | -24.51% | |||
| SG&A Expenses | -7.63% | 65.82% | |||
| Depreciation & Amortization | 2.08% | -35.73% | |||
| Other Operating Expenses | -11.76% | 65.31% | |||
| Total Operating Expenses | 0.77% | -3.29% | |||
| Operating Income | 38.53% | -37.00% | |||
| Income Before Tax | 1,078.79% | -107.75% | |||
| Income Tax Expenses | 316.67% | -108.82% | |||
| Earnings from Continuing Operations | 1,514.29% | -107.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -32.25% | 23.18% | |||
| Net Income | 58.22% | -139.33% | |||
| EBIT | 38.53% | -37.00% | |||
| EBITDA | 27.08% | -36.61% | |||
| EPS Basic | 58.38% | -138.65% | |||
| Normalized Basic EPS | 47.50% | -1,753.40% | |||
| EPS Diluted | 57.14% | -138.91% | |||
| Normalized Diluted EPS | 47.50% | -1,753.40% | |||
| Average Basic Shares Outstanding | 0.36% | 0.26% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||